T0	RelevantOutcomeExcluded 16658 16736	additional data on the clinical relevance of resistance with DAAs are required
T1	Population 18262 18372	the importance of the combination of these mutations is not well defined and needs to be investigated further.
T2	SampleSize 18504 18527	the limited sample size
T3	SampleSize 18940 18964	sample size limitations.
T4	SampleSize 19726 19743	small sample size
T5	UnbalancedGroups 19863 19893	discrepancies in baseline data
T6	UnbalancedGroups 19967 20030	baseline differences in HCV G4 subtype between treatment groups
T7	MissingData 20047 20125	sequencing and virologic response data could not be obtained for some patients
T8	Population 18529 18585	the lack of consistency of the mutations across patients
T9	UnderpoweredStudy 19748 19766	insufficient power
T10	SampleSize 19812 19846	The small population of this study
